Eris Lifesciences Ltd consolidated Q4FY23 PAT lower at Rs. 65.41 crores

Eris Lifesciences Limited has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 403.802 crores during the period ended March 31, 2023 as compared to Rs. 425.495 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 65.418 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 101.859 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 4.79 for the period ended March 31, 2023 as compared to Rs. 7.49 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹403.802 crs	₹425.495 crs	-5.10%
Net Profit	₹65.418 crs	₹101.859 crs	-35.78%
EPS	₹4.79	₹7.49	-36.05%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.403.802 crores during the period ended March 31, 2023 as compared to Rs.314.010 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.65.418 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.80.296 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.4.79 for the period ended March 31, 2023 as compared to Rs.5.91 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹403.802 crs	₹314.010 crs	28.60%
Net Profit	₹65.418 crs	₹80.296 crs	-18.53%
EPS	₹4.79	₹5.91	-18.95%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.1696.302 crores during the Financial Year ended March 31, 2023 as compared to Rs.1373.137 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.382.158 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.406.113 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.28.07 for the Financial Year ended March 31, 2023 as compared to Rs.29.88 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹1696.302 crs	₹1373.137 crs	23.53%
Net Profit	₹382.158 crs	₹406.113 crs	-5.90%
EPS	₹28.07	₹29.88	-6.06%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 631.90 as compared to the previous close of Rs. 632.45. The total number of shares traded during the day was 1079 in over 205 trades.

The stock hit an intraday high of Rs. 636.90 and intraday low of 628.25. The net turnover during the day was Rs. 681680.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q4FY23 FY2023 ResultUpdate